Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06760364
What this trial is testing

A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancers
Tianjin Medical University Cancer Institute and Hospital 21
Not applicableEnded earlyNCT01103128
What this trial is testing

Validation of a Mouse Model of Pancreatic Carcinogenesis

Who this might be right for
Pancreatic Cancer
Columbia University 450
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)Study completedNCT03415802
What this trial is testing

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Aiping Zhou 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05988372
What this trial is testing

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

Who this might be right for
Locally Advanced Pancreatic Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Study completedNCT03611556
What this trial is testing

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

Who this might be right for
CarcinomaMetastatic Pancreatic Adenocarcinoma
MedImmune LLC 213
Not applicableUnknownNCT04709445
What this trial is testing

Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses

Who this might be right for
Bowel ObstructionBowel IschemiaDiverticulitis+9 more
Charite University, Berlin, Germany 100
Not applicableStudy completedNCT06358001
What this trial is testing

EchoTip AcuCore Post-Market Clinical Study

Who this might be right for
AdenocarcinomaNeuroendocrine TumorsHepatocellular Carcinoma+5 more
Cook Research Incorporated 183
Testing effectiveness (Phase 2)UnknownNCT06345300
What this trial is testing

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Who this might be right for
Borderline Resectable Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Testing effectiveness (Phase 2)Ended earlyNCT01888965
What this trial is testing

Maintenance Dovitinib for Colorectal and Pancreas Cancer

Who this might be right for
Colorectal CancerPancreas Cancer
Georgetown University 9
Not applicableUnknownNCT05714475
What this trial is testing

Pancreas Resection for Colorectal Metastasis: Retrospective Study

Who this might be right for
Pancreas MetastasesColorectal Cancer
Ospedale Generale Di Zona Moriggia-Pelascini 15
Not applicableUnknownNCT05327400
What this trial is testing

Expression and Clinical Significance of IGHD in Pancreatic Cancer

Who this might be right for
Gene Expression
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06427239
What this trial is testing

Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Fudan University 130
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)WithdrawnNCT04037241
What this trial is testing

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Who this might be right for
Malignant Tumor of Pancreas Metastatic to Liver
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03891472
What this trial is testing

Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Cancer of PancreasUnresectable Pancreatic CancerChemotherapy Effect+1 more
Medical University of Silesia 40
Testing effectiveness (Phase 2)Study completedNCT03693677
What this trial is testing

First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

Who this might be right for
Metastatic Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 288
Next Page